BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11385416)

  • 1. Aurora throws light on Vertex's aspirations.
    Fletcher L
    Nat Biotechnol; 2001 Jun; 19(6):496. PubMed ID: 11385416
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescription for an ailing pharmaceutical industry.
    Demain AL
    Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmas partner in venture seeking drug discovery tools.
    Mack GS
    Nat Biotechnol; 2008 Sep; 26(9):960-1. PubMed ID: 18779790
    [No Abstract]   [Full Text] [Related]  

  • 4. What's fueling the biotech engine?
    Aggarwal S
    Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotech boom.
    Jayaraman KS
    Nature; 2005 Jul; 436(7050):480-3. PubMed ID: 16049469
    [No Abstract]   [Full Text] [Related]  

  • 6. Rediscovering plant-based drugs.
    Littleton J; Falcone D; Davies HM
    Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
    [No Abstract]   [Full Text] [Related]  

  • 7. Gaining medical momentum.
    Blake D
    Nature; 2004 Jun; 429(6991 Suppl):19-23. PubMed ID: 15175707
    [No Abstract]   [Full Text] [Related]  

  • 8. Genomics joint venture 2.
    Davies MJ
    Trends Biotechnol; 2001 May; 19(5):163. PubMed ID: 11301124
    [No Abstract]   [Full Text] [Related]  

  • 9. HGS drug flop latest genomics setback.
    Reid B
    Nat Biotechnol; 2002 Jun; 20(6):533. PubMed ID: 12042841
    [No Abstract]   [Full Text] [Related]  

  • 10. [Will genes become an engine to the industry?].
    Nylund S; Sibakov M
    Duodecim; 2000; 116(16):1763-8. PubMed ID: 12001455
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotechnology in Ireland: hard work, money and the brain gain.
    O'Neill MF
    Drug Discov Today; 2007 Feb; 12(3-4):108-11. PubMed ID: 17275730
    [No Abstract]   [Full Text] [Related]  

  • 12. Building for an exit (or not).
    Gunning TG
    Nat Biotechnol; 2008 Sep; 26(9):971-3. PubMed ID: 18792427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The production capacity bottleneck.
    De Keyser JL
    Nat Biotechnol; 2001 Aug; 19(8):715. PubMed ID: 11479555
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotech at the beauty counter.
    Nasto B
    Nat Biotechnol; 2007 Jun; 25(6):617-9. PubMed ID: 17557090
    [No Abstract]   [Full Text] [Related]  

  • 15. Sunbaked biotechnology in Australia.
    Littlejohn T
    Nat Biotechnol; 2002 Sep; 20(9):873-7. PubMed ID: 12205502
    [No Abstract]   [Full Text] [Related]  

  • 16. Merck wipes Serono off Swiss biotech map.
    Urquhart L
    Nat Biotechnol; 2006 Nov; 24(11):1303. PubMed ID: 17093457
    [No Abstract]   [Full Text] [Related]  

  • 17. Best-selling human medicines 2002-2004.
    Maggon K
    Drug Discov Today; 2005 Jun; 10(11):739-42. PubMed ID: 15922927
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotechs hold their own in shifting industry.
    Mitchell P
    Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
    [No Abstract]   [Full Text] [Related]  

  • 19. The number on biotech indexes.
    Jacobs T
    Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059
    [No Abstract]   [Full Text] [Related]  

  • 20. The view from the top.
    Howard K
    Nature; 2003 Dec; 426(6967):696-7. PubMed ID: 14668873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.